News

Medical Students Will Learn How to Set Up Their Start-ups

14.10.2019

RVC in conjunction with the I.M.Sechenov First MGMU will develop a specialized course on technological entrepreneurship for inclusion in the educational programs of medical and classical universities. The students of the course will learn to develop their own projects and work on the commercialisation of technologies in the field of medicine, pharmaceuticals and healthcare.

The biotechnology and digital healthcare segment is one of the fastest growing markets, however it places particular demands on the professionalism of teams. The cycle of development of core projects takes significantly longer than in IT or industry. In addition, biotechnology is notable for the high cost of research, the need for multiphase clinical trials of drugs and medical devices. In 2018, deals in the biotech segment accounted for only 3.3% of the total venture capital market in Russia. The introduction of the RVC course will expand the number of potential projects in this area.

The course will be practical. During the training, students, masters, graduate students will work in a team on an entrepreneurial project and study real examples from the industry. The training materials will include video lectures by leading industry experts, which can then be used for online training.

The course will be tested in the spring semester of 2019–20 academic year at the Sechenov First Moscow State Medical University, then he will be replicated to other universities. St. Petersburg State University of Chemical Pharmaceuticals, Samara State Medical University, and Novgorod State University have already showed interest in the introduction of the course.

Alexey Gusev, Director for Development of the RVC Innovation Ecosystem
The implementation of the course meets the objectives of RVC on entrepreneurship development in the interests of the markets of the National Technology Initiative. In this case, the Helsnet market. An important feature of the format of the course is its interdisciplinary nature. We expect that students and post-graduate students of different specializations, and ideally, from different faculties or even universities, will study. If programmers will join a team from a medical university, then, obviously, the effectiveness of such a team for working with projects in the field of healthcare digitalization will increase. We will experiment on platforms for inter-university formats, such as the NTI University 20.35, for example.
Vadim Tarasov, the Director of the Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University
The objective of the course is to identify those who have a propensity for entrepreneurial activity, and to form an understanding of the principles of developing drugs or medical devices, as well as skills to prepare their own project for presentation to investors or state support funds. Separately, I note that in no case do we set ourselves the task of making entrepreneurs out of doctors, but give basic knowledge about the creation of innovative medicines and medical devices. Understanding and complying with the logic of investors, pharmaceutical companies and, ultimately, the healthcare system that buys most medicines and medical devices is key to the success of the project.

Representatives of the pharmaceutical industry and government regulators are also involved in the course development process. The purpose of this involvement is the maximum practicality of educational content. Industry experts can act as guest speakers or as mentors for specific projects.

Mikhail Samsonov, R-Pharm Medical Director and Head of the NTI Helsnet Regulatory Work Group
Such a program will allow students to gain experience in real projects in demand in the field of health. Design experience is exactly what even the most capable graduates often lack. Without extensive training on the principles of project work, it is difficult to count on a long-term steady stream of new developments in the field of medical technology and pharmaceuticals.

In 2018, RVC jointly with Moscow State University named after M.V. Lomonosov and ITMO University developed a training course "Innovative Economics and Technological Entrepreneurship." The course has been introduced into the programs of more than 50 universities in 32 regions of Russia.



Search by name:

Search by date:

Select date in calendar
Select date in calendar
Venue: